missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 15819668

CD57 Mouse anti-Human, Unlabeled, Clone: HNK-1, BD

Mouse Monoclonal Antibody

Brand:  BD Biosciences 559048

Product Code. 15819668

  • ONLINE EXCLUSIVE PRICE
    £310.00
    £297.17 / Each
    Save £12.83
    4% Off

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Anti-HNK-1 monoclonal antibody recognizes a 110 kD glycoprotein (CD57) that is expressed on a subset of natural killer (NK) lymphocytes and T lymphocytes. It also recognizes epitopes on neural or neuroectodermal tumors including neurofibromas, malignant melanomas, malignant peripheral neuroectodermal tumors, Ewing's sarcomas, and small-cell lung carcinomas. Anti-HNK-1 monoclonal antibody also recognizes a carbohydrate epitope on subpopulations of several cell-adhesion molecules including N-CAM and myelin-associated glycoprotein (MAG).

TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD57
Monoclonal
1.0mg/mL
Aqueous buffered solution containing ≤0.09% sodium azide.
Membrane extracts of the HSB-2 T-lymphoblastoid cell line
0.2 mg
Immunology
Human
IgM κ
Flow Cytometry
HNK-1
Unconjugated
Mouse
Affinity Purified
RUO
Primary
Store undiluted at 4°C
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.